(Q70980348)
Statements
Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload (English)
D'Haese PC
De Broe ME
Goodman WG
Lemoniatou E
Digenis P
Sotornik I
Fagalde A
Barsoum RS
1 October 1995